The sales are routine and likely driven by tax or liquidity needs following the director stock grants. No bearish read-through. Monitor for any C-suite insider sales or a material increase in sale volume (>0.5% of market cap) before adjusting stance.
Price Chart
Executive Summary
Two Keros Therapeutics directors sold a combined $56K in open-market sales on June 4, 2026, following a round of non-cash stock grants to the same directors on June 3. The sales are trivial relative to the $204M market cap (0.03%) and are likely liquidity-driven after the grants, not a bearish signal. The cluster is not amplified by any cross-filing context (no earnings, offering, or late-filing events nearby).
Key Financial Metrics
Key Facts
- Two directors (Seth Alpna and Knowles Julius) each sold 2,625 shares on June 4, 2026, at ~$10.72-$10.73, totaling $56,306.
- Both sales occurred one day after each director received non-cash stock grants (7,433 and 7,142 shares respectively) on June 3, 2026.
- Total sale value of $56K represents only 0.03% of KROS's $204M market cap — well below the 0.1% materiality threshold.
- No C-suite executives participated in the sales; only two directors sold.
- No recent earnings, offering, restructuring, or late-filing events are present to amplify the cluster's signal.
Financial Impact
Total open-market sales of $56,306, or 0.03% of market cap — immaterial.
Risk Factors
- If additional insiders (especially C-suite) begin selling in the coming weeks, the pattern could become more concerning.
- KROS has a history of negative T+20 returns on neutral reports (avg -2.57%), but this cluster is too small to drive that.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KROS-1780951066902 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 23d ago | 8-K | $11.31 $11.04 | ▼ −2.39% | ▼ −2.05% | $11.17 (−1.24%) |
Aug 20, 2026 6w ago | Insider Cluster | $10.95 $11.23 | ▲ +2.56% | ▲ +1.44% | $11.17 (+2.01%) |
Aug 3, 2026 8w ago | 8-K | $10.25 $10.64 | ▲ +3.80% | ▲ +3.90% | $11.17 (+8.98%) |
Aug 3, 2026 8w ago | Press Release | $10.25 $10.64 | ▲ +3.80% | ▲ +3.90% | $11.17 (+8.98%) |
Jul 30, 2026 9w ago | 8-K | $10.07 $11.15 | ▲ +10.72% | ▲ +7.21% | $11.17 (+10.92%) |
Jul 22, 2026 10w ago | 8-K | $10.14 $10.22 | ▲ +0.79% | ▲ +0.31% | $11.17 (+10.16%) |
Jun 17, 2026 15w ago | Insider Cluster | $10.65 $10.41 | ▼ −2.25% | ▼ −0.59% | $11.17 (+4.88%) |
Jun 8, 2026 16w ago | Insider Cluster | $10.07 $10.24 | ▲ +1.69% | ▼ −0.72% | $11.17 (+10.92%) |
May 14, 2026 20w ago | 8-K | $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $11.17 (−1.64%) |
May 14, 2026 20w ago | Press Release | $10.99 $11.22 | ▼ −2.09% | ▼ −2.81% | $11.17 (−1.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access